| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
| 04/11/1996 | CA2201353A1 The taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 04/11/1996 | CA2200629A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 04/11/1996 | CA2160100A1 Carbohydrate conjugates as inhibitors of cell adhesion |
| 04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
| 04/10/1996 | EP0705606A1 Use of 5-Thia-1,4-diazabicyclo [4.2.0] octane-3,8-dioxo compounds in antitumor therapy |
| 04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
| 04/10/1996 | EP0705270A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 04/10/1996 | EP0705264A1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 04/10/1996 | EP0705261A1 Antiproliferative naphthyridines |
| 04/10/1996 | EP0705255A1 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes |
| 04/10/1996 | EP0705250A1 Bis-imide polycyclic and heterocyclic chromophores useful as tumoricidals |
| 04/10/1996 | EP0705098A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
| 04/10/1996 | EP0649429A4 Heteroatomic oligonucleoside linkages. |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120047A New peptide compound and a process for the preparation thereof |
| 04/10/1996 | CN1120046A Lobaplatin-Trihydrat |
| 04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
| 04/09/1996 | US5506249 Antiinflammatory, antiproliferative and antitumor activity |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506232 High purity antitumor agents with reduced side effects |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
| 04/04/1996 | WO1996010034A2 Thiol-free inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010028A1 PYRROLO[2,3-d]PYRIMIDINES AND THEIR USE |
| 04/04/1996 | WO1996010011A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009836A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
| 04/04/1996 | WO1996009828A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 04/04/1996 | WO1996009821A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996009820A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | CA2201350A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | CA2200210A1 Pyrrolo[2,3-d]pyrimidines and their use |
| 04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
| 04/03/1996 | EP0704526A1 hTFIIIA gene |
| 04/03/1996 | EP0704431A2 Ortho-substituted benzoic acid derivatives |
| 04/03/1996 | EP0704209A1 Transdermally active pharmaceutical composition containing 5-aminolaevulinic acid |
| 04/03/1996 | EP0703988A1 Mesothelial cell gene therapy |
| 04/03/1996 | EP0703979A1 Method for treating kaposi's sarcoma with antisense oligonucleotides |
| 04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
| 04/03/1996 | EP0703909A1 $g(D)?6,7 -TAXOLS ANTINEOPLASTIC USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
| 04/03/1996 | EP0703905A1 Inhibitors of farnesyl-protein transferase |
| 04/03/1996 | EP0703787A1 Cell growth regulators |
| 04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0494247B1 Reducing non-target retention of immunoconjugates and metabolites thereof |
| 04/03/1996 | EP0478715B1 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1996 | EP0445280B1 Therapeutic agent and method of inhibiting vascularization of tumors |
| 04/03/1996 | EP0328589B1 Tetra-aza macrocycles and metal complexes thereof |
| 04/03/1996 | CN1119860A Method for purifying taxoids |
| 04/03/1996 | CN1119858A New 4-aminopyridines, process for preparing the same and medicaments containing the same |
| 04/03/1996 | CN1119854A Acylfulvene analogues as antitumor agents |
| 04/03/1996 | CN1119643A Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their ... |
| 04/02/1996 | US5504216 Method for reparing an amorphous sulfonamide |
| 04/02/1996 | US5504212 Inhibitors of farnesyl-protein transferase |
| 04/02/1996 | US5504205 Reduced sp3 texaphyrins |
| 04/02/1996 | US5504191 Human cancer inhibitory pentapeptide methyl esters |
| 04/02/1996 | US5504189 Peptides, their preparation and use |
| 04/02/1996 | US5504115 Inhibitors of farnesyl protein transferase |
| 04/02/1996 | US5504103 Contacting cells with antitumor agents |
| 04/02/1996 | US5504102 Solution of teniposide, paclitaxel, or camptothecin and derivatives antitumor agent and polyethoxylated castor oil mixed with acid to lower the carboxylate anion content; shelf-life, by-product inhibition |
| 03/28/1996 | WO1996009551A1 Detection and treatment of cancer |
| 03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | WO1996009387A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | WO1996009380A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009309A1 The oligosaccharide structure of a ligand for e and p selectin |
| 03/28/1996 | WO1996009294A1 Substituted heteroaromatic compounds and their use in medicine |
| 03/28/1996 | WO1996009072A1 Estramustine formulations with improved pharmaceutical properties |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009060A1 Cell growth regulator |
| 03/28/1996 | WO1996009055A1 New use of prostaglandins |
| 03/28/1996 | WO1996009051A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | WO1996009046A1 5α-REDUCTASE INHIBITORS |
| 03/28/1996 | WO1996009041A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | WO1996009039A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | CA2200611A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | CA2200449A1 Naphthyl compounds, intermediates, processes, compositions, and methods |
| 03/28/1996 | CA2200205A1 A method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs |
| 03/28/1996 | CA2200204A1 Benzothiophene compounds, compositions, and methods |
| 03/28/1996 | CA2197490A1 Detection and treatment of cancer |
| 03/28/1996 | CA2174968A1 Estramustine formulations with improved pharmaceutical properties |
| 03/27/1996 | EP0703231A1 2-(4-Hydroxyphenyl)benzothiophene compounds, compositions and methods for alleviating the symptoms of post-menopause syndrome |
| 03/27/1996 | EP0703228A1 Naphthyl compounds, intermediates, processes, compositions involving them |
| 03/27/1996 | EP0703221A1 5 alpha-reductase Inhibitors |
| 03/27/1996 | EP0702961A2 Compositions for minimizing the uterotrophic effect of tamoxifen and its analogs |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702683A1 06-substituted guanine derivatives, a process for their preparation and their use in treating tumour cells |
| 03/27/1996 | EP0702563A1 Compositions and methods for treating cancer and hyperproliferative disorders |
| 03/27/1996 | EP0495053B1 New linker for bioactive agents |
| 03/27/1996 | CN1119459A Process for preparing cancer vaccines |
| 03/27/1996 | CN1119440A 2,6-diaminopurine derivatives |
| 03/27/1996 | CN1119183A Ortho-amino-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 03/27/1996 | CN1119111A Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 03/26/1996 | US5502094 Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods for use |
| 03/26/1996 | US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |